LifeSensors Awarded U.S. Patent for Novel Ubiquitin Pathway Enzyme Substrates
LifeSensors, Inc., a biotech company developing cutting-edge technologies for studying the ubiquitin pathway, has been awarded a U.S. patent for the development of novel, fluorescent di- and poly-ubiquitin deubiquitinase (DUB) substrates (US 8,518,660). Read More >>
LifeSensors is a proud sponsor of the 5th Annual Ubiquitin Drug Discovery & Diagnostics Conference
This year's conference will be held at the Four Seasons Hotel in Philadelphia, July 22-24 and will once again highlight the latest research taking place in the ubiquitin field. We are excited to learn about all of the latest discoveries and technical advances and hope to see you there! Visit Site >>
LifeSensors presented an overview of ubiquitin proteomics at the 3rd GTC Conference, Ubiquitin Research and Drug Discovery, Las Vegas, February 25-26th, 2013.
Complexity of ubiquitin pathways leads to frequent questions related to identification of ubiquitin pathway enzymes (E3s and DUBs) and their substrates. An overview of biochemical proteomics for drug discovery applications including Ubiquitin Protein Microarray Services from LifeSensors was presented by Christian Loch, Assistant Director, R&D. Visit our website to find additional information about our Ubiquitin Protein Microarrays. Visit Site >>